Osilodrostat

Overview

Osilodrostat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3099695).

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Osilodrostat expires 12 Oct 2035 and exclusivity 15 Apr 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile

Canonical SMILES

C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F

InChIKey

USUZGMWDZDXMDG-CYBMUJFWSA-N